Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Virology. 2017 May 2;508:1–6. doi: 10.1016/j.virol.2017.04.031

Fig 2.

Fig 2

DENV- and WNV-elicited mAbs bind to ZIKV PRVABC59. We tested a panel of mAbs for binding to ZIKV PRVABC59 (blue line) or a no-antigen control (black line) by ELISA. Samples were run in triplicate and data are shown as mean +/− SD. Data shown are representative of 3 independent experiments. We included the ZIKV-0402166 mAb (ZIKV-elicited) as a positive control and 170-3C12 mAb (influenza virus-elicited) as a negative control. Binding curves were calculated using one-site specific binding. We tested 54 mAbs and shown are the mAbs where the ZIKV ELISA signal was >2x the ELISA signal of the mAb against a no-antigen control and of the irrelevant influenza virus-specific mAb (170-3C12).